This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Roche Glycart Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Tony Christopeit: Innovator in Antibody Research
Introduction
Tony Christopeit is a notable inventor based in Schliersee, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work is recognized for its potential impact on therapeutic applications.
Latest Patents
Tony Christopeit holds a patent for "Antibodies Binding to GPRC5D." This innovation showcases his expertise in creating targeted therapies that could enhance treatment options for various diseases.
Career Highlights
Tony is currently employed at Roche Glycart AG, a leading company in the field of biopharmaceuticals. His role involves extensive research and development, focusing on innovative solutions in antibody technology. With 1 patent to his name, he has established himself as a key player in his area of expertise.
Collaborations
Throughout his career, Tony has collaborated with talented professionals, including Stefan Lorenz and Georg Fertig. These partnerships have fostered a creative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Tony Christopeit exemplifies the spirit of innovation in the biotechnology sector. His contributions, particularly in antibody research, highlight the importance of collaboration and creativity in driving scientific progress.